Glucose oxidase loaded Cu2+ based metal-organic framework for glutathione depletion/reactive oxygen species elevation enhanced chemotherapy

Jinzhi Xu,Yan Xu,Lixin Sun,Bei Lu,Xi Yan,Zhonghao Wang,Tong Zhang
DOI: https://doi.org/10.1016/j.biopha.2021.111606
2021-09-01
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Introduction</h3><p>The development of multidrug resistance (MDR) is a major cause for the failure of chemotherapy, which requires the aid of nanomedicine.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Here in our study, a Cu<sup>2+</sup> based metal-organic framework (COF) was firstly developed and employed as a carrier for the delivery of glucose oxidase (GOx) and doxorubicin (Dox) (COF/GOx/Dox) for the therapy of MDR lung cancers.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Our results showed that the GOx can catalyze glucose and produce H<sub>2</sub>O<sub>2</sub>. In the mean time, the Cu<sup>2+</sup> can react with GSH and then transform into Cu<sup>+</sup>, which resulted in GSH depletion. Afterwards, the produced Cu<sup>+</sup> and H<sub>2</sub>O<sub>2</sub> trigger Fenton reaction to generate ROS to damage the redox equilibrium of cancer cells. Both effects contributed to the reverse of MDR in A549/Dox cells and finally resulted in significantly enhanced in vitro/in vivo anticancer performance.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Discussion</h3><p>The combination of glutathione depletion/reactive oxygen species elevation might be a promising strategy to enhance the efficacy of chemotherapy and reverse MDR in cancers.</p>
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?